SILO 0.96 (-8.57%)
US82711P2011BiotechnologyBiotechnology

SILO Pharma (SILO) Financial Metrics

This table shows a selected set of financial data points of SILO Pharma (SILO). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2022 -1.71 0 -1.96 7.68M -0.35 72.1K -3.5M -3.58M -3.91M 11.37M
2021 2.06 0 3.48 13.57M 0.66 71.26K -2.28M -2.89M 3.9M 9.84M
2020 -2.3 0 0 0 -3.16 40.92K -1.16M -2.02M -3.04M 1.13M
2019 -2.16 0 0 0 -1.5 40.57K -794.32K -902.27K -1.01M 111.75K
2018 -0.99 0 0 0 -0.78 0 272.64K -947.7K -969.46K 336.68K
2017 0.36 0 0 0 0.24 847.41K -284.62K 377.02K 356.54K 294.59K
2016 -1.11 0 0 0 -0.59 -669.48K -143.56K -1.06M -1.11M 579.21K
2015 -0.4 0 0 0 -0.16 -145.19K -1.02M -409.5K -409.5K 722.76K
2014 -0.39 0 0 0 -0.15 -107.11K -1.06M -376.55K -376.55K 1.74M
2013 0.05 0 0 0 0.03 105.52K -181.61K 32.91K 32.91K 2.01M
2012 -0.06 0 0 0 -38.84 0 -21.47K -39.45K -39.45K 279
2011 -0.08 0 0 0 0 0 -46.3K -49.8K -49.8K 1.75K

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.